Roop K. Lakkaraju - Mar 3, 2025 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO BIO.B)

Role
EVP, Chief Financial Officer
Signature
/s/ Roop K. Lakkaraju
Stock symbol
BIO BIO.B
Transactions as of
Mar 3, 2025
Transactions value $
$0
Form type
4
Date filed
3/5/2025, 04:59 PM
Previous filing
Mar 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIO BIO.B Bio-Rad A Common Stock 87.5 Mar 3, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIO.B Non-Qualified Stock Option (right to buy) Award $0 +3.89K $0.00 3.89K Mar 3, 2025 Bio-Rad A Common Stock 3.89K $256.45 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 61.7090 and 25.7940 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2024 and 12/31/2024, respectively.
F2 The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.